Infections after keratoprosthesis

Current Opinion in Ophthalmology

Volumn 27, Issue 4, 2016, Pages 373-377

  Davies, Emma ^a   Chodosh, James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

endophthalmitis; keratoprosthesis; microbial keratitis

Indexed keywords

QUINOLONE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL KERATITIS; ENDOPHTHALMITIS; FUNGAL ENDOPHTHALMITIS; HUMAN; KERATITIS; KERATOPROSTHESIS; MULTICENTER STUDY (TOPIC); POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; UNITED STATES; VITRITIS; ADVERSE EFFECTS; ARTIFICIAL ORGAN; CORNEA; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; MICROBIOLOGY; POSTOPERATIVE COMPLICATION; PROSTHESES AND ORTHOSES; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDY; SURGERY;

ANTI-BACTERIAL AGENTS; ARTIFICIAL ORGANS; CORNEA; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES;

EID: 84965008225     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000270     Document Type: Review

References (22)

1. Ma J, Graney J, Dohlman C. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin 2005; 45:49-59.
2. Aldave A, Sangwan V, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology 2012; 119:1530-1538.
3. Nouri M, Terada H, Alfonso E, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001; 119:484-489.
4. Robert M, Harissi-Dagher M. Boston type I keratoprosthesis: the CHUM experience. Can J Ophthalmol 2011; 46:164-168.
5. Khan B, Harissi-Dagher M, Khan D, et al. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007; 47:61-71.
6. Rai R, Shorter E, Cortina M, et al. Contact lens surveillance cultures in Boston type I keratoprosthesis patients. Eye Contact Lens 2013; 39:175-178.
7. Durand M, Dohlman C. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009; 28:896-901.
8. Chan C, Holland E. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 2012; 31:346-349.
9. Fintelmann R, Maguire J, Ho A, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 2009; 28:877-878.
10. Ramchandran R, DiLoreto D, Chung M, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology 2012; 119:674-681.
11. Kim M, Yu F, Aldave A. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 2013; 120:2209-2216.
12. Lee W, Shtein R, Kaufman S, et al. Boston keratoprosthesis: outcomes and complications. Ophthalmology 2015; 122:1504-1511.
13. Zarei-Ghanavati S, Irandoost F. Treatment of refractory keratitis after a Boston type I keratoprosthesis with corneal collagen cross-linking. Cornea 2015; 34:1161-1163.
14. Oliveira L, Magalhaes F, Hirai F, et al. Experience with Boston keratoprosthesis type I in the developing world. Can J Ophthalmol 2014; 40:351-357.
15. Lekhanont K, Thaweesit P, Muntham D, et al. Medium-term outcomes of Boston type I keratoprosthesis implantation in Bangkok, Thailand. Cornea 2014; 33:1312-1319.
16. Srikumaran D, Munoz B, Aldave A, et al. Long-term outcomes of Boston type I keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 2014; 121:2159-2164.
17. Chhablani J, Panchal B, Das T, et al. Endophthalmitis in Boston keratoprosthesis: case series and review of literature. Int Ophthalmol 2015; 35:673-678.
18. Ciolino J, Belin M, Todani A, et al. Retention of the Boston keratoprosthesis type I: multicenter study results. Ophthalmology 2013; 120:1195-1200.
19. Behlau I, Martin K, Martin J, et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol 2014; 92:e546-e555.
20. Arfaj K. Boston keratoprosthesis-Clinical outcomes with wider geographic use and expanding indications-A systematic review. Saudi J Ophthalmol 2015; 29:212-221.
21. Grassi C, Crnej A, Paschalis E, et al. Idiopathic vitritis in the setting of Boston keratoprosthesis. Cornea 2015; 34:165-170.
22. Grassi C, Chodosh J. Causes of sterile vitritis in the setting of Boston keratoprosthesis. Spektrum der Augenheilkunde 2014; 28:234-237.